| Anthony William Opipari Jr, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Anthony William Opipari Jr |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184711947 | NPI | - | NPPES |
| 3490934 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301063648 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony William Opipari Jr, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Anthony William Opipari Jr, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Patients with "masked" hypertension that is not detected by routine office blood pressure measurements appear to have stroke and death rates similar to that of patients with sustained high blood pressure; whereas patients with so-called "white coat" hypertension appear to have no greater risk than people with normal blood pressure, according to a new study in the Aug. 2, 2005, issue of the Journal of the American College of Cardiology.
Scientists in the United States suggest a blood test widely used to screen for prostate cancer can be misleading in the case of men who are obese.
A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial.
United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.
Bowel Cancer UK is pleased to announce that the charity will be part of the lead committee on bowel cancer in the Genomics England genome sequencing project.
› Verified 4 days ago
Evangelia Lea Lazaris, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Olivia Winfrey, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Ellery Grace Sarosi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanne Vicari Block, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd Ste 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 | |
Aisha Yousuf, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, L4100 Womens, Ann Arbor, MI 48109 Phone: 734-936-9434 Fax: 734-647-1006 | |
Dr. Edwin Peter Peterson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 375 W Northfield Church Rd, Ann Arbor, MI 48105 Phone: 734-663-1705 Fax: 734-663-1302 | |
Dr. Ashley Mia Dowgiert, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd, Suite 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 |